SCHEMBL29910361

SCHEMBL29910361

CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCC(N)C(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.57

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.57
▸ CNR1 P21554 3/20 0.54
▸ SELP P16109 1/20 0.46
▸ NR5A2 O00482 1/20 0.44
▸ NR5A1 Q13285 1/20 0.44
▸ P2RY10 O00398 5/20 0.43
▸ GPR34 Q9UPC5 2/20 0.43
▸ FABP3 P05413 1/20 0.43
▸ GPR174 Q9BXC1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23521224 1.00 CNR2 (0.57) CNR2CNR1SELPNR5A2NR5A1
SCHEMBL23142625 0.93 CNR2 (0.56) CNR2CNR1SELPNR5A2NR5A1
SCHEMBL23142658 0.93 CNR2 (0.58) CNR2CNR1P2RY10GPR34GPR174
SCHEMBL2012311 0.85 CNR2 (0.49) CNR2CNR1
Phosphorylethanolamine SCHEMBL5671550 0.85 CNR2 (0.57) CNR2CNR1
SCHEMBL10140249 0.81 CNR2 (0.66) CNR2CNR1FABP3
SCHEMBL12989865 0.80 CNR2 (0.68) CNR2CNR1FABP3
Biotin SCHEMBL17338714 0.79 CNR2 (0.60) CNR2CNR1
SCHEMBL23209666 0.78 SELP (0.71) SELPP2RY10GPR34FABP3
SCHEMBL23256430 0.78 SELP (0.71) SELPP2RY10GPR34FABP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351600-A1 METHODS OF ACTIVATING T CELLS ADOC SSF, LLC (US) 2024-04-17 — — EP claimed
CN-117835992-A Method for activating T cells PACT制药公司 2024-04-05 — — CN claimed
CN-112469826-B Magnetic-based biopanning method by attachment of magnetic beads to cells (株)爱恩德生物 2024-02-09 — — CN claimed
WO-2022261392-A1 METHODS OF ACTIVATING T CELLS PACT PHARMA, INC. (US) 2022-12-15 — — WO claimed
EP-4054532-A1 MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-09-14 — — EP disclosed
Send feedback